Title : Angiogenesis Promotion by Combined Administration of DFO and Vein Endothelial Cells Using Injectable, Biodegradable, Nanocomposite Hydrogel Scaffolds.

Pub. Date : 2022 Feb 21

PMID : 35045699






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Desferrioxamine (DFO) upregulates HIF-1alpha and stimulates expression of vascular endothelial growth factor (VEGF), thereby accelerating neovascularization. Deferoxamine vascular endothelial growth factor A Homo sapiens
2 Desferrioxamine (DFO) upregulates HIF-1alpha and stimulates expression of vascular endothelial growth factor (VEGF), thereby accelerating neovascularization. Deferoxamine vascular endothelial growth factor A Homo sapiens
3 Desferrioxamine (DFO) upregulates HIF-1alpha and stimulates expression of vascular endothelial growth factor (VEGF), thereby accelerating neovascularization. Deferoxamine vascular endothelial growth factor A Homo sapiens
4 Desferrioxamine (DFO) upregulates HIF-1alpha and stimulates expression of vascular endothelial growth factor (VEGF), thereby accelerating neovascularization. Deferoxamine vascular endothelial growth factor A Homo sapiens